Identification of Novel Components Influencing Colonization Factor Antigen I Expression in Enterotoxigenic Escherichia coli

PLoS One. 2015 Oct 30;10(10):e0141469. doi: 10.1371/journal.pone.0141469. eCollection 2015.

Abstract

Colonization factors (CFs) mediate early adhesion of Enterotoxigenic Escherichia coli (ETEC) in the small intestine. Environmental signals including bile, glucose, and contact with epithelial cells have previously been shown to modulate CF expression in a strain dependent manner. To identify novel components modulating CF surface expression, 20 components relevant to the intestinal environment were selected for evaluation. These included mucin, bicarbonate, norepinephrine, lincomycin, carbon sources, and cations. Effects of individual components on surface expression of the archetype CF, CFA/I, were screened using a fractional factorial Hadamard matrix incorporating 24 growth conditions. As most CFs agglutinate erythrocytes, surface expression was evaluated by mannose resistant hemagglutination. Seven components, including porcine gastric mucin, lincomycin, glutamine, and glucose were found to induce CFA/I surface expression in vitro in a minimal media while five others were inhibitory, including leucine and 1,10-phenanthroline. To further explore the effect of components positively influencing CFA/I surface expression, a response surface methodology (RSM) was designed incorporating 36 growth conditions. The optimum concentration for each component was identified, thereby generating a novel culture media, SP1, for CFA/I expression. CFs closely related to CFA/I, including CS4 and CS14 were similarly induced in SP1 media. Other epidemiologically relevant CFs were also induced when compared to the level obtained in minimal media. These results indicate that although CF surface expression is complex and highly variable among strains, the CF response can be predicted for closely related strains. A novel culture media inducing CFs in the CF5a group was successfully identified. In addition, mucin was found to positively influence CF expression in strains expressing either CFA/I or CS1 and CS3, and may function as a common environmental cue.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adhesins, Bacterial / biosynthesis
  • Adhesins, Bacterial / genetics
  • Animals
  • Bacterial Adhesion
  • Bacterial Toxins / analysis
  • Bacteriological Techniques
  • Cattle
  • Cell Wall / chemistry
  • Culture Media / chemistry
  • Culture Media / pharmacology*
  • Enterotoxigenic Escherichia coli / drug effects*
  • Enterotoxigenic Escherichia coli / genetics
  • Enterotoxigenic Escherichia coli / metabolism
  • Enterotoxigenic Escherichia coli / pathogenicity
  • Enterotoxins / analysis
  • Enzyme-Linked Immunosorbent Assay
  • Escherichia coli Proteins / analysis
  • Escherichia coli Proteins / biosynthesis*
  • Escherichia coli Proteins / genetics
  • Fimbriae Proteins / biosynthesis*
  • Fimbriae Proteins / genetics
  • Gene Expression Regulation, Bacterial / drug effects*
  • Glutamine / pharmacology
  • Hemagglutination Tests
  • Humans
  • Intestines / chemistry
  • Intestines / microbiology
  • Lincomycin / pharmacology
  • Mucins / pharmacology
  • Sus scrofa
  • Swine
  • Virulence / drug effects

Substances

  • Adhesins, Bacterial
  • Bacterial Toxins
  • Culture Media
  • Enterotoxins
  • Escherichia coli Proteins
  • Mucins
  • colonization factor antigens
  • Glutamine
  • Fimbriae Proteins
  • Lincomycin
  • heat-labile enterotoxin, E coli

Grants and funding

Sanofi Pasteur provided support in the form of salaries for SG, SH and GR-M, and a research grant for SH through EZUS, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The decision to publish was validated by the Sanofi Pasteur legal team and senior management of the Research department, and was limited solely to the verification that the manuscript did not contravene company policy concerning the release of proprietary information.